Other OTC Pharmaceuticals (Pharmacies) - Kyrgyzstan

  • Kyrgyzstan
  • Revenue in the Other OTC Pharmaceuticals market is projected to reach US$3.19m in 2024.
  • Revenue is expected to show an annual growth rate (CAGR 2024-2029) of 0.68%, resulting in a market volume of US$3.30m by 2029.
  • In global comparison, most revenue will be generated in the United States (US$4,981.00m in 2024).
  • In relation to total population figures, per person revenues of US$0.47 are generated in 2024.

Key regions: France, Australia, India, South Korea, Germany

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Other OTC Pharmaceuticals (Pharmacies) market in Kyrgyzstan is experiencing steady growth due to changing customer preferences, emerging trends, and local special circumstances. Customer preferences in the Other OTC Pharmaceuticals (Pharmacies) market in Kyrgyzstan are shifting towards self-medication and convenience. Consumers are increasingly seeking over-the-counter medications for common ailments and minor health issues, as they provide quick relief without the need for a doctor's prescription. This preference for self-medication is driven by factors such as affordability, accessibility, and convenience. In addition, consumers are becoming more health-conscious and proactive in managing their own health, which further fuels the demand for over-the-counter pharmaceuticals. Trends in the market include the rising popularity of natural and herbal remedies, as consumers seek alternative and holistic approaches to healthcare. This trend is driven by a growing awareness of the potential side effects of synthetic medications and a desire for more natural and sustainable solutions. As a result, pharmacies in Kyrgyzstan are expanding their product offerings to include a wide range of natural and herbal remedies, catering to the evolving needs and preferences of consumers. Another trend in the market is the increasing use of online platforms for purchasing over-the-counter pharmaceuticals. E-commerce has gained significant traction in Kyrgyzstan, providing consumers with a convenient and hassle-free way to purchase medications. Online pharmacies offer a wide selection of products, competitive prices, and doorstep delivery, making it an attractive option for consumers. This trend is likely to continue as internet penetration and smartphone usage increase in the country. Local special circumstances in Kyrgyzstan also contribute to the development of the Other OTC Pharmaceuticals (Pharmacies) market. The country has a relatively underdeveloped healthcare infrastructure, with limited access to healthcare facilities in rural areas. This lack of accessibility drives consumers to rely on over-the-counter medications for self-treatment. Additionally, the cost of prescription medications and doctor consultations can be prohibitive for some individuals, leading them to opt for over-the-counter alternatives. Underlying macroeconomic factors, such as population growth, increasing disposable income, and urbanization, also play a role in the growth of the Other OTC Pharmaceuticals (Pharmacies) market in Kyrgyzstan. The country's growing population and rising income levels contribute to higher healthcare expenditure and increased demand for over-the-counter medications. Urbanization further fuels this demand, as urban areas tend to have higher concentrations of pharmacies and better access to healthcare services. In conclusion, the Other OTC Pharmaceuticals (Pharmacies) market in Kyrgyzstan is developing due to changing customer preferences, emerging trends, local special circumstances, and underlying macroeconomic factors. The shift towards self-medication, the popularity of natural and herbal remedies, the rise of online platforms, limited healthcare accessibility, and favorable macroeconomic conditions all contribute to the growth of the market.

Methodology

Data coverage:

The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.

Modeling approach:

Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.

Additional notes:

The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.

Overview

  • Revenue
  • Analyst Opinion
  • Global Comparison
  • Methodology
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Kisara Mizuno
Kisara Mizuno
Senior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)